Introduction
The basic principles of nucleic acid amplification technology (NAT) and definitions of the various techniques are covered in
Nucleic Acid-Based TechniquesGeneral
1125
. The current chapter covers general steps in the extraction and purification of nucleic acids from a variety of samples.
The expanding discipline of molecular biology in pharmaceutical and biomedical research and development is characterized by the rapid discovery of new markers for disease and technologies for their detection. Nucleic acid targets are isolated from a wide variety of specimens, and the quality and quantity of the extracted target are highly affected by specimen collection, handling, and choice of extraction procedure.
The analysis of complex organisms by molecular biological techniques requires the isolation of pure, high molecular weight genomic DNA and intact full-length RNA. The application of these techniques then allows the detection, identification, and characterization of the associated organism or adventitious agent. Recently developed tests employing purified human DNA enable genetic testing for the presence, predisposition, or carrier status of inherited diseases such as cystic fibrosis, hereditary hemochromatosis, or TaySachs disease, to name a few examples, or the analysis of single nucleotide polymorphisms (SNPs).
DNase and RNase are the major sources of nucleic acid instability. Although both enzymes are ubiquitous and are easily released during nucleic acid extraction, RNases are far more stable and harder to inactivate than are DNases because they generally do not require co-factors in order to function. Minute amounts of RNase are sufficient to destroy RNA, so great care should be taken to avoid inadvertently introducing these enzymes into the sample during or after the isolation procedure. If RNA is collected for the specific application of gene expression analysis, researchers should keep in mind that the sample collection process itself can alter the resulting expression profile.
Because of the ubiquity of RNases, measurement of intracellular RNA targets has lagged behind that of DNA targets in contributing to patient management and characterization of targets for pharmaceutical purposes. However, RNA represents the current status of the organism and is an important tool for correlating a phenotype with its associated genetic activity. The unstable nature of RNA has made standardization of NAT tests difficult, and false negative results can easily arise from a poorly handled sample because of target degradation rather than from the absence of disease or regulation of gene activity. Nevertheless, commercially available isolation and detection systems provide a high level of standardization and robustness, resulting in the implementation of RNA-based assays in recent years. The following sections discuss general steps in the extraction and purification of nucleic acids from a variety of samples, focusing on (1) collection, handling and storage of samples; (2) disruption of samples; (3) subsequent extraction and purification of nucleic acids; and (4) storage of purified nucleic acids.
Pre-Analytical Steps and Sample Collection
Although the genetic makeup of the organism remains mostly unchanged over time, the mRNA population represents the current status of a cell under any given set of conditions, and thus is highly dynamic. To prevent degradation of mRNA and/or to preserve the original transcription pattern of the cellular mRNA, tissue should be placed immediately on ice or snap-frozen in liquid nitrogen. However, freezing disrupts the cellular structure and releases RNases. Hence, for RNA isolation in general (mRNA, ribosomal RNA, viral RNA, etc.), thawing in an RNase-inactivating buffer is essential. A more convenient procedure employs a stabilizing agent at ambient temperature. Several reagents for different types of sample material (e.g., tissue or bacteria) are commercially available. Vanadium salts were once used to inhibit RNase activity, but they have been superseded by the use of chaotropic agents for the inhibition of RNase and stabilization of RNA. The sample can easily be collected in such reagents and stored for several days to weeks prior to RNA isolation.
For reliable gene-expression analysis, the immediate stabilization of the RNA expression pattern and of the RNA itself is an absolute prerequisite. Directly after the biological sample is harvested or extracted, changes in the gene-expression pattern occur because of specific and nonspecific RNA degradation as well as transcriptional induction. Such changes in the gene-expression pattern should be avoided for all reliable quantitative gene-expression analyses, such as biochip and array analyses and quantitative reverse transcription-polymerase chain reaction (RT-PCR).
The use of gloves while handling reagents and RNA samples is mandatory to prevent RNase contamination arising from contact with the surface of the skin or from laboratory equipment. In order to create and maintain an RNase-free environment, laboratory personnel should treat water or buffer solutions with diethylpyrocarbonate (DEPC), which inactivates RNases by covalent chemical modification. Care should be taken because DEPC is irritating to the eyes, skin, and mucous membranes and is also a suspected carcinogen. Alternatively, commercially available RNase-free solutions and reagents may be used. Commercially available RNase inhibitor proteins are also available for use in reactions but with different levels of effectiveness with respect to various RNase types. However, it should be noted that DEPC cannot be used with Tris-buffered solutions. Many scientists recommend the use of disposable vessels when working with RNA. Nondisposable glassware should be cleaned with a detergent, thoroughly rinsed, and oven baked at 240

for 4 or more hours before use (autoclaving alone will not fully inactivate many RNases). Alternatively, glassware can also be treated with DEPC. Nondisposable plasticware should be thoroughly rinsed with 0.1 M sodium hydroxide and 1 mM EDTA, followed by RNase-free water. Alternatively, chloroform-resistant plasticware can be rinsed with chloroform to inactivate RNases. The use of aerosol-resistant filter tips is also important for avoiding RNase contamination. These issues are not critical for DNA, and following the rules of Good Laboratory Practice (GLP) is generally sufficient for successful isolation of DNA.
As a general precaution, staff should follow all applicable safety precautions when handling tissue or body fluids (human or other). Some of these precautions (e.g., the use of disposable gloves) also prevent contamination of the sample. Applicable guidelines and standards for the collection and processing of human-derived materials have been published by the American Association of Blood Banks, the International Conference on Harmonization, and the FDA.
Sample Disruption and Homogenization
Prior to extraction, source material is disrupted and homogenized. Disruption is the complete breakage of cell walls and plasma membranes of solid tissues and cells in order to release all DNA and RNA contained in the specimen. This is usually done using a lysis buffer that also inactivates endogenous nucleases. In addition to disrupting tissues, homogenization shears high molecular weight DNA and cellular components. During RNA isolation, scientists often must reduce the viscosity of cell lysates (caused by the presence of high molecular weight DNA molecules) prior to final isolation in order to make the subsequent extraction steps easier and more efficient. Incomplete homogenization may interfere with subsequent RNA purification steps (e.g., inefficient binding of RNA to silica membranes) and therefore result in significantly reduced yields. A typical procedure to shear high molecular weight DNA and homogenize the sample is to repeatedly pass the lysate through a small-gauge needle. However, this procedure is time-consuming and is not suitable for high throughput of samples. Better procedures to achieve complete disruption and homogenization of cells and tissue include rapid agitation in the presence of beads and lysis buffer (bead milling) or rotorstator homogenization.
During the bead milling process, disruption and simultaneous homogenization occur by the shearing and crushing action of the beads as they collide with the cells. Disruption efficiency is influenced by the size and composition of the beads, the speed and configuration of the agitator, the ratio of buffer to beads, the disintegration time, and the amount of starting material. These parameters must be determined empirically for each application. For disruption with mortar and pestle, the samples should be frozen in liquid nitrogen and ground to a fine powder under liquid nitrogen. Standard safety precautions and the use of safety clothing to protect the skin and eyes should be employed when working with liquid nitrogen. Rotorstator homogenizers are able to disrupt and homogenize animal and plant tissues within 5 to 90 seconds, depending on the sample. The rotor turns at very high speed, causing the sample to be disrupted by a combination of turbulence and mechanical shearing. Other alternatives are commercial spin-column homogenizers in combination with silica-membrane technology, which provide a fast and efficient way to homogenize cell and tissue lysates without cross-contamination of samples.
In order to achieve complete disruption, different sample types require different procedures. Cells from tissue culture grown as a monolayer or in suspension are easily disrupted by the addition of a lysis buffer that typically contains a mixture of an anionic detergent, a protease, and a chaotropic agent in a buffered salt solution. In contrast, nucleic acid isolation from fibrous tissues such as skeletal muscle, heart, and aorta can be difficult to disrupt because of the abundance of contractile proteins, connective tissue, and collagen. Fresh or frozen tissue samples should be cut into small pieces to aid lysis. Blood samples, including those treated to remove erythrocytes, can be efficiently lysed using a lysis buffer and a proteinase.
In general, the same procedures are applicable for extraction of DNA and RNA. For DNA isolation more gentle procedures are preferable, but during RNA isolation, cells and tissues can be disrupted using a mixer mill because there is no risk of shearing the RNA. Certain downstream applications require high molecular weight DNA, and care should be taken not to shear the DNA molecules and thus render the DNA unsuitable for further analysis.
Extraction and Purification
Although several procedures are available for nucleic acid extraction, the suitability of a procedure depends on the starting material, the type and purity of nucleic acid isolated, and possibly the downstream application. The principal procedures are described below; several commercial kits are available to accommodate different sample types and applications.
Phase Extraction
The original technique for extraction of DNA and RNA from lysed samples is phase extraction, which involves nucleic acid extraction using a mixture of phenol and chloroform. Depending on pH and salt concentration, either DNA or RNA partitions in the aqueous phase. At neutral/basic pH, the DNA remains in the aqueous phase, and RNA remains in the organic phase or in the interphase (with the proteins). However, at acidic pH, DNA in the sample is protonated, neutralizing the charge and causing it to partition into the organic phase. RNA, which remains charged, partitions in the aqueous phase. The two phases are separated by centrifugation, and the aqueous phase is re-extracted with a mixture of phenol and chloroform, followed by extraction with chloroform to remove any residual phenol. The nucleic acid is recovered from the aqueous phase by precipitation with alcohol. For RNA, this procedure is often combined with a protease digestion, alcohol or lithium chloride precipitation, and/or cesium chloride (CsCl) density gradients. A potential problem is contamination of the recovered DNA or RNA with organic solvents that may interfere with enzymatic downstream applications or spectrometry readouts.
Cesium Chloride Density Gradient Centrifugation
For the isolation of high molecular weight genomic DNA, CsCl density gradient centrifugation is the traditional procedure. Cells are lysed using a detergent, and the DNA is isolated from the lysate by alcohol precipitation. The DNA is then mixed with CsCl and ethidium bromide and centrifuged for several hours at a high g force (typically 100,000 × g). The DNA band, which can be visualized under UV light as a result of the intercalation of the ethidium bromide with the DNA, is collected from the centrifuge tube, extracted with isopropanol to remove the ethidium bromide, and then precipitated with ethanol to recover the DNA. This procedure allows the isolation of high-quality DNA, but it is time consuming and also a safety concern because of the high quantity of EtBr involved.
Anion-Exchange Chromatography
An alternative procedure for the purification of high molecular weight genomic DNA is anion-exchange chromatography based on the interaction between the negatively charged phosphate groups of the nucleic acid and positively charged surface molecules on the anion-exchange resin. Binding occurs under low-salt conditions, and impurities such as RNA, cellular proteins, and metabolites are washed away using medium-salt buffers. Pure DNA is eluted with a high-salt buffer and is desalted and concentrated by alcohol precipitation. This procedure yields DNA of a purity and biological activity equivalent to two rounds of purification in CsCl gradients, but in much less time. The procedure also avoids the use of toxic substances, and it can be adapted for different scales of purification. DNA up to 150 kilobases (kb) in length may be isolated using this procedure. Several kits are available for the isolation of DNA based on anion-exchange technology, and procedures vary in processing times and the quality and size of the isolated DNA.
Silica Technology
The current procedure of choice for most applications is based on silica technology and can be used for isolation of full-length RNA or DNA with an average size of 20 to 50 kb. However, higher molecular weight DNA exceeding 100 kb is not efficiently extracted by this technology. The procedure relies on the selective adsorption of nucleic acids to silica in the presence of high concentrations of chaotropic salts. Although both types of nucleic acid adsorb to silica, the use of specific buffers in the lysis procedure ensures that only the desired nucleic acid is adsorbed while other nucleic acids, cellular proteins, and metabolites remain in solution. The contaminants are washed away, and high-quality RNA or DNA is eluted from the silica using a low-salt buffer. The silica matrix can be used as particles in suspension, in the form of magnetic beads, or as a membrane. This technique is suitable for high throughput, and several kits and automated systems are commercially available. However, these aqueous lysis buffers (in contrast to lysis buffers based on an organic solvent such as phenol) are not ideally suited for difficult-to-lyse samples (e.g., fatty tissues). Kits designed to facilitate lysis of fatty tissues and to inhibit RNases are available. Silica-based kits provide a fast and reliable procedure for both DNA and RNA purification and are commonly used for nucleic acid extraction.
Although these procedures yield pure nucleic acids, for some applications in which even trace contaminations with either RNA or DNA may interfere, pretreatment with DNase or RNase may be necessary. Alternatively, procedures that use specific probe capture may be used. Relevant applications requiring such ultra-pure nucleic acids are discussed in
Nucleic Acid-Based TechniquesAmplification
1127
.
Specific Applications for Hard-to-Extract Materials
Extraction from Formalin-Fixed and Paraffin-Embedded Biopsies
The nucleic acids in formalin-fixed paraffin embedded (FFPE) biopsies are usually heavily fragmented and chemically modified by formaldehyde. Although formaldehyde modification cannot be detected in standard quality control assays such as gel electrophoresis, formaldehyde modification does interfere with enzymatic analyses. Sufficient extraction and demodification for DNA can be achieved by prolonged digestion with protease, but this will lead to heavy fragmentation and degradation of RNA. Some isolation systems have been optimized to reverse as much formaldehyde modification as possible without further RNA degradation. Nevertheless, RNA purified from FFPE samples should not be used in downstream applications that require full-length RNA. Some applications may require modifications to allow the use of fragmented RNA (e.g., designing small amplicons for RT-PCR).
Extraction from Bacteria and Pathogens
Although Gram-negative bacteria are relatively easy to lyse, Gram-positive bacteria or yeasts typically need an enzymatic pretreatment to remove the cell wall for efficient lysis. This methodology can be applied only to DNA isolation because the enzymatic treatment will influence the expression profile of the organism, and therefore RNA isolation requires a more rapid lysis procedure. Another factor to consider is that microorganisms normally occur against the background of a host or an environmental matrix (e.g., soil), which makes detection by polymerase chain reaction (PCR) often difficult because of inhibitory components. This means that the isolation procedure has to be carefully adapted and optimized for the specific organism and sample type. Commercial kits are available, and most are based on the use of lysozyme for the removal of cell walls.
Special Considerations for Limited Sample Amounts
Multiple genetic testing techniques, including SNP analysis, short tandem repeat analysis, sequencing or genotyping using arrays, real-time PCR, and other procedures depend on the availability of high-quality DNA. Because human genomic DNA or samples of individual genotypes are often limited, a process to immortalize nucleic acid samples can overcome this limitation. Procedures applicable to genotyping are discussed in
Nucleic Acid-Based TechniquesGenotyping
1129
. Whole-genome amplification (WGA) has recently been employed to amplify limited genomic DNA from already purified DNA or directly from clinical or casework samples without any DNA purification. Two basic technologies for WGA are available and are PCR-based or rely on isothermal multiple-displacement amplification. These applications are described in more detail in
Nucleic Acid-Based TechniquesAmplification
1127
.